• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Eli Lilly

Eli Lilly

Eli Lilly and Co LLY

Last Price$78.46Day Change (%)0.41%
Open Price$78.20Day Change ($)0.32
Day Range77.46–78.7552-Week Range67.88–92.85

As of Thu 6/30/2016 2:40:00 PM | USD

  1. Key Pharma News Issue - Transforming Cancer Treatment Paradigms Will Drive Record FDA Approvals - Research and Markets

    Key Pharma News Issue - Transforming Cancer Treatment Paradigms Will Drive Record FDA Approvals - Research and Markets

  2. $39.4 Billion Biomarkers Report: Technologies and Global Markets to 2020 - Research and Markets

    $39.4 Billion Biomarkers Report: Technologies and Global Markets to 2020 - Research and Markets

  3. Global Hypercholesterolemia Pipeline Report 2016 - Therapeutics Review of 36 Companies & Drug Profile Activity - Research and Markets

    Global Hypercholesterolemia Pipeline Report 2016 - Therapeutics Review of 36 Companies & Drug Profile Activity - Research and Markets

  4. Why Are Primecap Funds So Sustainable?

    These Gold-rated funds have Morningstar Sustainability Ratings of High despite not explicitly trying to do so.

  5. Lilly: German Supreme Court Grants Appeal in Dispute With Actavis

    Lilly: German Supreme Court Grants Appeal in Dispute With Actavis

  6. Nuclear Medicine/Radiopharmaceuticals Global Market - Forecast to 2022 - Increasing Therapeutic Application Areas - Research and Markets

    Nuclear Medicine/Radiopharmaceuticals Global Market - Forecast to 2022 - Increasing Therapeutic Application Areas - Research and Markets

  7. Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Allergan, Pfizer, ICStudy - Research and Markets

    Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Allergan, Pfizer, ICStudy - Research and Markets

  8. Why Aren't Low Rates Working? Blame Dividends

    Why Aren't Low Rates Working? Blame Dividends

  9. Global Pioglitazone Patent, Extension and Data Exclusivity Expiry Snapshot Report 2016 - Research and Markets

    Global Pioglitazone Patent, Extension and Data Exclusivity Expiry Snapshot Report 2016 - Research and Markets

  10. Fitch Rates Indiana Finance Auth. First Lien Water Utility Revs 'A'; Outlook Stable

    Fitch Rates Indiana Finance Auth. First Lien Water Utility Revs 'A'; Outlook Stable

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.